Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-29.68%
↓ 63% below average
Average (4y)
-18.17%
Historical baseline
Range
High:-1.31%
Low:-40.44%
CAGR
+118.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -29.68% | +26.6% |
| 2023 | -40.44% | -216.3% |
| 2022 | -12.78% | -93.1% |
| 2021 | -6.62% | -404.6% |
| 2020 | -1.31% | - |